Sign Out
The following undesirable effects have been observed during placebo-controlled clinical trials (n=2344) and post-marketing with the indicated frequencies as follows: See table.
Click on icon to see table/diagram/imageReporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions.
View ADR Reporting Link
